Bottom line
DLHIX vs SCHLX: the short answer
DLHIX (Nomura Healthcare Fund) and SCHLX (DWS Health and Wellness Fund) share a meaningful slice of their top holdings — about 44% by weight.
DLHIX is cheaper at 0.96% vs 1.06% — a difference of $10 a year per $10,000 invested.
Updated Nov 19, 2026
DLHIX vs SCHLX side by side
| DLHIX | SCHLX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Voya | DWS (Xtrackers) |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.96% | 1.06% |
| Annual cost per $10k | $96 | $106 |
| 10-yr cost on $10k (prospectus) | $1,232 | $1,294 |
| Max front load | 0% | 0% |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +22.4% | — |
| 5-yr return (annualized) | +7.8% | — |
| 10-yr return (annualized) | +10.4% | — |
| Best quarter | — | — |
| Worst quarter | — | — |
| Net assets (fund) | $750.2M | $231.8M |
| Number of holdings | 108 | 65 |
| Portfolio turnover | 4% | 2% |
| Returns as of | Dec 31, 2025 | — |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
12 of DLHIX's top 25 holdings also appear in SCHLX's top 25.
| Holding | DLHIX | SCHLX |
|---|---|---|
| Abbvie Inc | 4.19% | 4.90% |
| Eli Lilly & Company | 4.16% | 13.85% |
| Regeneron Pharmaceuticals Inc | 3.91% | 1.43% |
| Unitedhealth Group Inc | 3.88% | 5.73% |
| Pfizer Inc | 3.84% | 1.17% |
| Merck & Company Inc | 3.68% | 4.85% |
| Gilead Sciences Inc | 3.54% | 2.78% |
| Astrazeneca Plc | 3.27% | 3.80% |
| Roche Holding Ag | 3.01% | 1.24% |
| Amgen Inc | 2.27% | 2.88% |
| Vertex Pharmaceuticals Inc | 1.66% | 2.45% |
| Boston Scientific Corp | 1.42% | 2.10% |
Source: SEC Form N-PORT
DLHIX top 10
- Ucb Sa — 5.19%
- Abbvie Inc — 4.19%
- Eli Lilly & Company — 4.16%
- Regeneron Pharmaceuticals Inc — 3.91%
- Unitedhealth Group Inc — 3.88%
- Pfizer Inc — 3.84%
- Merck & Company Inc — 3.68%
- Gilead Sciences Inc — 3.54%
- Astrazeneca Plc — 3.27%
- Elevance Health Inc — 3.25%
SCHLX top 10
- Eli Lilly & Co — 13.85%
- Johnson & Johnson — 6.19%
- UnitedHealth Group Inc — 5.73%
- AbbVie Inc — 4.90%
- Merck & Co Inc — 4.85%
- AstraZeneca PLC — 3.80%
- Thermo Fisher Scientific Inc — 3.46%
- Novartis AG — 2.90%
- Amgen Inc — 2.88%
- Gilead Sciences Inc — 2.78%
FAQ
What is the difference between DLHIX and SCHLX?
DLHIX (Nomura Healthcare Fund) and SCHLX (DWS Health and Wellness Fund) share a meaningful slice of their top holdings — about 44% by weight. DLHIX is cheaper at 0.96% vs 1.06% — a difference of $10 a year per $10,000 invested.
Which is cheaper, DLHIX or SCHLX?
DLHIX has the lower expense ratio (0.96%).
Should I own both DLHIX and SCHLX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.